Table 2.
Medical conditions | Number of approaches included | References to papers of the review |
---|---|---|
Acute medical conditions | 28.6% | (3, 10, 15–24) |
COVID-19 | 11.9% | (25–29) |
Cancer | 11.9% | (30–34) |
Hip fracture | 4.8% | (35, 36) |
COPD | 4.8% | (37, 38) |
Orthogeriatric conditions | 4.8% | (39, 40) |
Inflammatory or malignant bowel disease | 2.4% | (41) |
Hematological malignancies | 2.4% | (42) |
Neuromuscular disease with respiratory tract infections | 2.4% | (43) |
Congestive heart failure, chronic obstructive pulmonary disease, community acquired pneumonia, diabetic foot ulcer, complicated wound care | 2.4% | (44) |
Chronic pain and severe disabling spasticity | 2.4% | (45) |
Nosocomial infections | 2.4% | (46) |
Multiple sclerosis | 2.4% | (47) |
Pediatric care | 2.4% | (48) |
COPD, congestive heart failure, deep vein thrombosis, asthma, community-acquired pneumonia | 2.4% | (49) |
Heart failure, endocarditis | 2.4% | (50) |
Gastroenteritis | 2.4% | (51) |
Artificial heart-supported patients | 2.4% | (52) |
Schizophrenia, bipolar mood, unipolar mood, neurotic disorders | 2.4% | (53) |
Heart failure | 2.4% | (54) |